Cited by 762Histone Deacetylase Inhibitors ResearchGenomics and Chromatin DynamicsEpigenetics and DNA Methylation

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Enzymatic Activity Associated with Class II HDACs Is Dependent on a Multiprotein Complex Containing HDAC3 and SMRT/N-CoR

Open access

Fischle, Wolfgang, Dequiedt, Franck, Hendzel, Michael J, Guenther, Matthew G, Lazar, Mitchell A, Voelter, Wolfgang, Verdin, Eric·2002·Molecular Cell

DOI 10.1016/s1097-2765(01)00429-4

Open this paper in CoChat — free account Open PDF

Abstract

Histone deacetylases (HDACs) play a key role in regulating eukaryotic gene expression. The HDAC domain, homologous to the yeast repressors RPD3 and HDA1, is considered necessary and sufficient for enzymatic activity. Here, we show that the catalytic domain of HDAC4 interacts with HDAC3 via the transcriptional corepressor N-CoR/SMRT. All experimental conditions leading to the suppression of HDAC4 binding to SMRT/N-CoR and to HDAC3 result in the loss of enzymatic activity associated with HDAC4. In vitro reconstitution experiments indicate that HDAC4 and other class II HDACs are inactive in the context of the SMRT/N-CoR-HDAC3 complex and do not contribute to its enzymatic activity. These observations indicate that class II HDACs regulate transcription by bridging the enzymatically active SMRT/N-CoR-HDAC3 complex and select transcription factors independently of any intrinsic HDAC activity.

Integrity signals

Registry

Crossref · 10.1016/s1097-2765(01)00429-4

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Crystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466
Current protocols in molecular biology
Sargent, T. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90147-9 · Cited by 7,281
Histone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor
Hörlein, A., Näär, A. M., Heinzel, T., Torchia, J., Gloss, B. R., Kurokawa, R., Ryan, A. K., Kamei, Y., Söderström, M., Glass, C. K., et al. (1995) · Nature · doi:10.1038/377397a0 · Cited by 2,072
Twenty-Five Years of the Nucleosome, Fundamental Particle of the Eukaryote Chromosome
Kornberg, R. D., & Lorch, Y. (1999) · Cell · doi:10.1016/s0092-8674(00)81958-3 · Cited by 1,833
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.
Osborn, L., Kunkel, S. L., & Nabel, G. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2336 · Cited by 1,583

Show all 60 references

Sorted by citations

Items 101–200 of 762

Nuclear hormone receptor co-repressors: Structure and function
Watson, P. J., Fairall, L., & Schwabe, J. W. R. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.033 · Cited by 164
Histone Deacetylases in Bone Development and Skeletal Disorders
Bradley, E. W., Shull, L. C., van Wijnen, A. J., McGee‐Lawrence, M. E., & Westendorf, J. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00004.2015 · Cited by 163
Two Catalytic Domains Are Required for Protein Deacetylation
Zhang, Y., Gilquin, B., Khochbin, S., & Matthias, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500241200 · Cited by 161
Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer
Hou, P., Kapoor, A., Zhang, Q., Li, J., Wu, C.-J., Li, J., Lan, Z., Tang, M., Ma, X., Ackroyd, J. J., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0597 · Cited by 154
Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression
Jacobs, F. M. J., van Erp, S., van der Linden, A. J. A., von Oerthel, L., Burbach, J. P. H., & Smidt, M. P. (2009) · Development · doi:10.1242/dev.029769 · Cited by 159
HDAC5 Controls MEF2C-Driven Sclerostin Expression in Osteocytes
Wein, M. N., Spatz, J., Nishimori, S., Doench, J., Root, D., Babij, P., Nagano, K., Baron, R., Brooks, D., Bouxsein, M., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2381 · Cited by 158
Expression of HDAC1 and CBP/p300 in human colorectal carcinomas
Ishihama, K., Yamakawa, M., Semba, S., Takeda, H., Kawata, S., Kimura, S., & Kimura, W. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.029165 · Cited by 157
Histone deacetylases: target enzymes for cancer therapy
Mottet, D., & Castronovo, V. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9131-5 · Cited by 158
HDAC4 represses p21WAF1/Cip1 expression in human cancer cells through a Sp1-dependent, p53-independent mechanism
Mottet, D., Pirotte, S., Lamour, V., Hagedorn, M., Javerzat, S., Bikfalvi, A., Bellahcène, A., Verdin, E. M., & CASTRONOVO, V. (2008) · Oncogene · doi:10.1038/onc.2008.371 · Cited by 162
Self-citation
HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells
Urbich, C., Rössig, L., Kaluza, D., Potente, M., Boeckel, J., Knau, A., Diehl, F., Geng, J.-G., Hofmann, W., Zeiher, A. M., et al. (2009) · Blood · doi:10.1182/blood-2009-01-196485 · Cited by 156
Histone Deacetylase 7 Associates With Runx2 and Represses Its Activity During Osteoblast Maturation in a Deacetylation-Independent Manner
Jensen, E. D., Schroeder, T. M., Bailey, J., Gopalakrishnan, R., & Westendorf, J. J. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.071104 · Cited by 158
Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface
McKinsey, T. A., & Kass, D. A. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2193 · Cited by 152
Caspase-dependent Regulation of Histone Deacetylase 4 Nuclear-Cytoplasmic Shuttling Promotes Apoptosis
Paroni, G., Mizzau, M., Henderson, C. J., Sal, G. D., Schneider, C., & Brancolini, C. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-08-0624 · Cited by 149
Development of histone deacetylase inhibitors for cancer treatment
Marchion, D. C., & Münster, P. N. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.4.583 · Cited by 153
Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
Verza, F. A., Das, U., Fachin, A. L., Dimmock, J. R., & Marins, M. (2020) · Cancers · doi:10.3390/cancers12061664 · Cited by 149
HDAC4 and PCAF Bind to Cardiac Sarcomeres and Play a Role in Regulating Myofilament Contractile Activity
Gupta, M. P., Samant, S. A., Smith, S. H., & Shroff, S. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710277200 · Cited by 147
Histone deacetylase function in CD4+ T cells
Ellmeier, W., & Seiser, C. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0037-z · Cited by 146
Glucocorticoid Receptor (GR)-Associated SMRT Binding to C/EBPβ TAD and Nrf2 Neh4/5: Role of SMRT Recruited to GR in GSTA2 Gene Repression
Ki, S. H., Cho, I. J., Choi, D. W., & Kim, S. G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4150-4165.2005 · Cited by 145
Next-generation of selective histone deacetylase inhibitors
Yang, F., Zhao, N., Ge, D., & Chen, Y. (2019) · RSC Advances · doi:10.1039/c9ra02985k · Cited by 145
Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease
Bürli, R. W., Luckhurst, C. A., Aziz, O., Matthews, K. L., Yates, D., Lyons, K. A., Beconi, M., McAllister, G., Breccia, P., Stott, A. J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4011884 · Cited by 153
Assembly of the SMRT–histone deacetylase 3 repression complex requires the TCP-1 ring complex
Guenther, M. G., Yu, J., Kao, G. D., Yen, T. J., & Lazar, M. A. (2002) · Genes & Development · doi:10.1101/gad.1037502 · Cited by 138
Self-citation
Protein Kinase D1 Phosphorylates HDAC7 and Induces Its Nuclear Export after T-cell Receptor Activation
Parra, M., Kasler, H. G., McKinsey, T. A., Olson, E. N., & Verdin, E. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413396200 · Cited by 141
Self-citation
N-CoR-HDAC Corepressor Complexes: Roles in Transcriptional Regulation by Nuclear Hormone Receptors
Jones, P. L., & Shi, Y. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-55747-7_9 · Cited by 137
Epigenetic regulation of nervous system development by DNA methylation and histone deacetylation
MacDonald, J. L., & Roskams, A. J. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.002 · Cited by 139
Hypoxia-Inducible Factor-1: A Critical Player in the Survival Strategy of Stressed Cells
Chen, S., & Sang, N. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25283 · Cited by 137
Strength in diversity: Understanding the pathways to herpes simplex virus reactivation
Suzich, J. B., & Cliffe, A. R. (2018) · Virology · doi:10.1016/j.virol.2018.07.011 · Cited by 144
HDAC signaling in neuronal development and axon regeneration
Cho, Y., & Cavalli, V. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.008 · Cited by 141
Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders
Konsoula, Z., & Barile, F. A. (2012) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2012.08.001 · Cited by 141
Nuts and bolts of the salt-inducible kinases (SIKs)
Darling, N. J., & Cohen, P. (2021) · Biochemical Journal · doi:10.1042/bcj20200502 · Cited by 134
Epigenetic regulation on gene expression induced by physical exercise.
Ntanasis‐Stathopoulos, I., Tzanninis, J. G., Philippou, Α., & Koutsilieris, M. (2013) · PubMed · Cited by 134
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC–MEF2 complexes
Nebbioso, A., Manzo, F., Miceli, M., Conte, M., Manente, L., Baldi, A., Luca, A. D., Rotili, D., Valente, S., Mai, A., et al. (2009) · EMBO Reports · doi:10.1038/embor.2009.88 · Cited by 132
Deacetylase Activity Is Required for Recruitment of the Basal Transcription Machinery and Transactivation by STAT5
Rascle, A., Johnston, J. A., & Amati, B. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4162-4173.2003 · Cited by 131
HDAC3 Is a Negative Regulator of Cocaine-Context-Associated Memory Formation
Rogge, G. A., Singh, H., Dang, R., & Wood, M. A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4472-12.2013 · Cited by 127
Beyond NF-κB activation: nuclear functions of IκB kinase α
Huang, W., & Hung, M. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-3 · Cited by 130
Regulation of Class IIa HDAC Activities: It is Not Only Matter of Subcellular Localization
Giorgio, E. D., & Brancolini, C. (2016) · Epigenomics · doi:10.2217/epi.15.106 · Cited by 129
Functional Interaction between Class II Histone Deacetylases and ICP0 of Herpes Simplex Virus Type 1
Lomonte, P., Thomas, J., Texier, P., Caron, C., Khochbin, S., & Epstein, A. L. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.6744-6757.2004 · Cited by 146
Subtype Selective Substrates for Histone Deacetylases
Heltweg, B., Dequiedt, F., Marshall, B. L., Brauch, C., Yoshida, M., Nishino, N., Verdin, E. M., & Jung, M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0497592 · Cited by 125
Self-citation
Histone deacetylases and epigenetic therapies of hematological malignancies
Mercurio, C., Minucci, S., & Pelicci, P. G. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.02.010 · Cited by 125
Profiling of Substrates for Zinc‐dependent Lysine Deacylase Enzymes: HDAC3 Exhibits Decrotonylase Activity In Vitro
Madsen, A. S., & Olsen, C. A. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203754 · Cited by 122
HDAC3 and the molecular brake pad hypothesis
McQuown, S. C., & Wood, M. A. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.04.005 · Cited by 126
Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis
Clocchiatti, A., Florean, C., & Brancolini, C. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01321.x · Cited by 127
Protein Acetylation in the Cardiorenal Axis
Bush, E. W., & McKinsey, T. A. (2010) · Circulation Research · doi:10.1161/circresaha.109.209338 · Cited by 121
Histone modifications and exercise adaptations
McGee, S. L., & Hargreaves, M. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00979.2010 · Cited by 120
AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1α and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol
Chen, S., Yin, C., Lao, T., Liang, D., He, D., Wang, C., & Sang, N. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1055426 · Cited by 127
Transgenic Overexpression of Hdac3 in the Heart Produces Increased Postnatal Cardiac Myocyte Proliferation but Does Not Induce Hypertrophy
Trivedi, C. M., Lu, M. M., Wang, Q., & Epstein, J. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803686200 · Cited by 119
Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases
Gupta, K. D., Shakespear, M. R., Iyer, A., Fairlie, D. P., & Sweet, M. J. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2015.46 · Cited by 116
MRF4 negatively regulates adult skeletal muscle growth by repressing MEF2 activity
Moretti, I., Ciciliot, S., Dyar, K. A., Abraham, R., Murgia, M., Agatea, L., Akimoto, T., Bicciato, S., Forcato, M., Pierre, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms12397 · Cited by 115
Dietary Inhibitors of Histone Deacetylases in Intestinal Immunity and Homeostasis
Schilderink, R., Verseijden, C., & de Jonge, W. J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00226 · Cited by 121
Nitric Oxide Modulates Chromatin Folding in Human Endothelial Cells via Protein Phosphatase 2A Activation and Class II Histone Deacetylases Nuclear Shuttling
Illi, B., Russo, C. D., Colussi, C., Rosati, J. D., Pallaoro, M., Spallotta, F., Rotili, D., Valente, S., Ragone, G., Martelli, F., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.157305 · Cited by 113
Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment
Isaacs, J. T., Antony, L., Dalrymple, S. L., Brennen, W. N., Gerber, S., Hammers, H., Wissing, M., Kachhap, S., Luo, J., Xing, L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2730 · Cited by 116
Histone deacetylases in skeletal development and bone mass maintenance
McGee‐Lawrence, M. E., & Westendorf, J. J. (2010) · Gene · doi:10.1016/j.gene.2010.12.003 · Cited by 113
Histone acetylation in drug addiction
Renthal, W., & Nestler, E. J. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.01.005 · Cited by 109
The Thyroid Hormone-Regulated Corepressor Hairless Associates with Histone Deacetylases in Neonatal Rat Brain
Potter, G. B., Zarach, J. M., Sisk, J. M., & Thompson, C. C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0115 · Cited by 112
Histone Deacetylase 3 Depletion in Osteo/Chondroprogenitor Cells Decreases Bone Density and Increases Marrow Fat
Razidlo, D. F., Whitney, T. J., Casper, M. E., McGee‐Lawrence, M. E., Stensgard, B. A., Li, X., Secreto, F. J., Knutson, S. K., Hiebert, S. W., & Westendorf, J. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011492 · Cited by 113
Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer
Martínez-Iglesias, O. A., Ruiz-Llorente, L., Sánchez‐Martínez, R., García, L. D. D., Zambrano, A., & Aranda, A. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0221-x · Cited by 112
Transcriptional Coregulators: Fine-Tuning Metabolism
Mouchiroud, L., Eichner, L. J., Shaw, R. J., & Auwerx, J. H. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.027 · Cited by 116
Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion
Hong, S., Zhou, W., Fang, B., Lu, W., Loro, E., Damle, M., Ding, G., Jager, J., Zhang, S., Zhang, Y., et al. (2016) · Nature Medicine · doi:10.1038/nm.4245 · Cited by 112
Self-citation
Tup1-Ssn6 Interacts with Multiple Class I Histone Deacetylases in Vivo
Davie, J. K., Edmondson, D. G., Coco, C., & Dent, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309753200 · Cited by 110
In vitro nuclear interactome of the HIV-1 Tat protein
Gautier, V., Gu, L., O'Donoghue, N. M., Pennington, S. R., Sheehy, N., & Hall, W. W. (2009) · Retrovirology · doi:10.1186/1742-4690-6-47 · Cited by 111
Epigenetic modifications in the nervous system and their impact upon cognitive impairments
Rudenko, A., & Tsai, L. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.043 · Cited by 111
Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1
Wang, S., Jiang, B., Zhang, T., Liu, L., Wang, Y., Wang, Y., Chen, X., Lin, H., Zhou, L., Xia, Y., et al. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002243 · Cited by 112
Fasting and High-Fat Diet Alter Histone Deacetylase Expression in the Medial Hypothalamus
Funato, H., Oda, S., Yokofujita, J., Igarashi, H., & Kuroda, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018950 · Cited by 110
Histone deacetylases in cardiovascular and metabolic diseases
Bagchi, R. A., & Weeks, K. L. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.04.003 · Cited by 109
Zn(II)-dependent histone deacetylase inhibitors: Suberoylanilide hydroxamic acid and trichostatin A
Codd, R., Braich, N., Liu, J., Soe, C. Z., & Pakchung, A. A. H. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.05.026 · Cited by 109
Derepression of pathological cardiac genes by members of the CaM kinase superfamily
McKinsey, T. A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.11.036 · Cited by 109
Phosphoproteomic analysis reveals an intrinsic pathway for the regulation of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes
Navarro, M. N., Goebel, J., Feijoo‐Carnero, C., MORRICE, N. A., & Cantrell, D. A. (2011) · Nature Immunology · doi:10.1038/ni.2008 · Cited by 108
Myc-Mediated Transcriptional Repression by Recruitment of Histone Deacetylase
Kurland, J. F., & Tansey, W. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6552 · Cited by 107
Mechanism of Recruitment of Class II Histone Deacetylases by Myocyte Enhancer Factor-2
Han, A., He, J., Wu, Y., Liu, J. O., & Chen, L. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.10.033 · Cited by 107
Role of the Orphan Nuclear Receptor NR4A Family in T-Cell Biology
Odagiu, L., May, J., Boulet, S., Baldwin, T. A., & Labrecque, N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.624122 · Cited by 110
Smad-Dependent Recruitment of a Histone Deacetylase/Sin3A Complex Modulates the Bone Morphogenetic Protein-Dependent Transcriptional Repressor Activity of Nkx3.2
Kim, D., & Lassar, A. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8704-8717.2003 · Cited by 106
The Role of Histone Acetylation in Cocaine-Induced Neural Plasticity and Behavior
Rogge, G. A., & Wood, M. A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.154 · Cited by 109
HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder
Trazzi, S., Fuchs, C., Viggiano, R., Franceschi, M. D., Valli, E., Jedynak, P., Hansen, F. K., Perini, G., Rimondini, R., Kurz, T., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw231 · Cited by 101
Isoform-selective HDAC inhibitors: Closing in on translational medicine for the heart
McKinsey, T. A. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.11.009 · Cited by 103
FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3
Wang, L., Liu, Y., Han, R., Beier, U. H., Bhatti, T. R., Akimova, T., Greene, M. I., Hiebert, S. W., & Hancock, W. W. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77088 · Cited by 107
Chemical and structural biology of protein lysine deacetylases
Yoshida, M., Kudo, N., Kosono, S., & Ito, A. (2017) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.93.019 · Cited by 109
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
Wawruszak, A., Kałafut, J., Okoń, E., Czapiński, J., Hałasa, M., Przybyszewska-Podstawka, A., Miziak, P. A., Okła, K., Rivero‐Müller, A., & Stepulak, A. (2019) · Cancers · doi:10.3390/cancers11020148 · Cited by 102
Histone Deacetylase Inhibitors as Novel Anticancer Therapeutics
Walkinshaw, D. R., & Yang, X. (2008) · Current Oncology · doi:10.3747/co.v15i5.371 · Cited by 104
Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5pPreprint
Han, K., Gennarino, V. A., Lee, Y., Pang, K., Hashimoto‐Torii, K., Choufani, S., Raju, C. S., Oldham, M. C., Weksberg, R., RAKIC, P. T., et al. (2013) · Genes & Development · doi:10.1101/gad.207456.112 · Cited by 107
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases
JONES, P. G., Altamura, S., Francesco, R. D., Gallinari, P., Lahm, A., Neddermann, P., Rowley, M., Serafini, S., & Steinkühler, C. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.02.025 · Cited by 103
Epigenetics and Exercise
McGee, S. L., & Hargreaves, M. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.06.002 · Cited by 107
The methyl-CpG binding protein MBD1 is required for PML-RARα function
Villa, R., Morey, L., Raker, V. A., Buschbeck, M., Gutiérrez, A., Santis, F. D., Corsaro, M., Varas, F., Bossi, D., Minucci, S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509343103 · Cited by 100
HDAC inhibitors: a potential new category of anti-tumor agents.
Li, P., Lu, J., & Huang, B. (2007) · PubMed · Cited by 100
Small Molecule Inhibitors of Zinc-dependent Histone Deacetylases
Wagner, F. F., Weïwer, M., Lewis, M. C., & Holson, E. B. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0226-1 · Cited by 99
Transcription and beyond: the role of mammalian class I lysine deacetylases
Moser, M., Hagelkrüys, A., & Seiser, C. (2013) · Chromosoma · doi:10.1007/s00412-013-0441-x · Cited by 99
Integrated mechanisms of CaMKII-dependent ventricular remodeling
Kreußer, M. M., & Backs, J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00036 · Cited by 98
Posttranslational modifications of histone deacetylases: Implications for cardiovascular diseases
Eom, G. H., & Kook, H. Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.012 · Cited by 101
Breast cancer associated transcriptional repressor PLU‐1/JARID1B interacts directly with histone deacetylases
Barrett, A. N., Santangelo, S., Tan, K., Catchpole, S., Roberts, K., Spencer‐Dene, B., Hall, D., Scibetta, A. G., Burchell, J., Verdin, E. M., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22673 · Cited by 96
Self-citation
Towards Selective Inhibition of Histone Deacetylase Isoforms: What Has Been Achieved, Where We Are and What Will Be Next
Thaler, F., & Mercurio, C. (2013) · ChemMedChem · doi:10.1002/cmdc.201300413 · Cited by 99
Histone deacetylase inhibitors: Future therapeutics for insulin resistance and type 2 diabetes
Sharma, S., & Taliyan, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.009 · Cited by 98
Class IIa Histone Deacetylases Drive Toll-like Receptor-Inducible Glycolysis and Macrophage Inflammatory Responses via Pyruvate Kinase M2
Gupta, K. D., Shakespear, M. R., Curson, J. E. B., Murthy, A. M. V., Iyer, A., Hodson, M. P., Ramnath, D., Tillu, V. A., von Pein, J. B., Reid, R. C., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.007 · Cited by 101
Metabolic reprogramming by class I and II histone deacetylases
Mihaylova, M. M., & Shaw, R. J. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.09.003 · Cited by 100
Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts
Xia, S., Li, X., Johnson, T., Seidel, C. W., Wallace, D. P., & Li, R. (2010) · Development · doi:10.1242/dev.049437 · Cited by 98
Nonisotopic substrate for assaying both human zinc and NAD+-dependent histone deacetylases
Heltweg, B., Dequiedt, F., Verdin, E. M., & Jung, M. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(03)00276-8 · Cited by 95
Self-citation
Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors
Codina, A., Love, J. D., Li, Y., Lazar, M. A., Neuhaus, D., & Schwabe, J. W. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500299102 · Cited by 95
Self-citation
Post-translational Modifications Regulate Class IIa Histone Deacetylase (HDAC) Function in Health and Disease
Mathias, R. A., Guise, A. J., & Cristea, I. M. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o114.046565 · Cited by 93
Chromatin regulation in drug addiction and depression
Renthal, W. R., & Nestler, E. J. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.3/wrenthal · Cited by 92
Nuclear Import of Histone Deacetylase 5 by Requisite Nuclear Localization Signal Phosphorylation
Greco, T. M., Yu, F., Guise, A. J., & Cristea, I. M. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.004317 · Cited by 90
HDAC4 Controls Muscle Homeostasis through Deacetylation of Myosin Heavy Chain, PGC-1α, and Hsc70
Luo, L., Martin, S. C., Parkington, J. D., Cadena, S. M., Zhu, J., Ibebunjo, C., Summermatter, S., Londraville, N., Patora‐Komisarska, K., Widler, L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.023 · Cited by 93
Chemo-proteomics exploration of HDAC degradability by small molecule degraders
Xiong, Y., Donovan, K. A., Eleuteri, N. A., Kirmani, N., Yue, H., Razov, A., Krupnick, N. M., Nowak, R. P., & Fischer, E. S. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.07.002 · Cited by 91
Histone Deacetylase 3 Suppression Increases PH Domain and Leucine-rich Repeat Phosphatase (Phlpp)1 Expression in Chondrocytes to Suppress Akt Signaling and Matrix Secretion
Bradley, E. W., Shull, L. C., & Westendorf, J. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423723 · Cited by 91

Authors: Fischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E.
Affiliations: University of California, San Francisco (US)
University of Alberta (CA)
University of Pennsylvania (US)
University of Tübingen (DE)
Corresponding author: Verdin, Eric
ORCID: Fischle, Wolfgang
Hendzel, Michael J
Guenther, Matthew G
Lazar, Mitchell A
Voelter, Wolfgang
Verdin, Eric
Venue: Molecular Cell
Publisher: Elsevier BV
Published: 2002-01
Volume: 9
Issue: 1
Pages: 45-57
ISSN: 1097-2765 (ISSN-L)
DOI: 10.1016/s1097-2765(01)00429-4
OpenAlex: W2052373759
Cited by: 754
References: 60
Citations by year: 2026: 16 · 2025: 20 · 2024: 26 · 2023: 12 · 2022: 32 · 2021: 23 · 2020: 31 · 2019: 39 · 2018: 29 · 2017: 34 · 2016: 33 · 2015: 43 · 2014: 42 · 2013: 46 · 2012: 41
FWCI: 9.99
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 4215 d)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Molecular Cell (publishedVersion)
PubMed (publishedVersion)
MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
Max Planck Institute for Plasma Physics (submittedVersion)
Open Repository and Bibliography (University of Liège) (submittedVersion)
Funders: National Institute of General Medical Sciences (R01GM051671, GM51671)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords: histone deacetylase, class II HDACs, HDAC4, HDAC3, SMRT, NCoR, corepressors, protein complexes, transcriptional repression, gene expression regulation, repressors
MeSH terms: Histone Deacetylase 3, Amino Acid Sequence, DNA Mutational Analysis, DNA-Binding Proteins, Enzyme Activation, HeLa Cells, Histone Deacetylases, Humans, Molecular Sequence Data, Protein Binding, Repressor Proteins, Transcription, Genetic, Nuclear Receptor Co-Repressor 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Enzymatic Activity Associated with Class II HDACs Is Dependent on a Multiprotein Complex Containing HDAC3 and SMRT/N-CoR

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks